Neuland Lab Share Price

Neuland Lab Share Price

NSE: NEULANDLAB
|
Pharmaceuticals
|
S Cap
₹ 23,510.00
-₹485.00 (-2.02%)
1D
Last updated 09 Sep, 2026, 12:46 IST

Neuland Lab Share Price Today

As of 9 Sep 2026, Neuland Lab share price is ₹23,510.00. The stock opened at ₹24,000.00, compared to its previous close of ₹23,995.00. During today's trading session, Neuland Lab share price moved in the range of ₹23,460.00 to ₹24,225.00, with an average price of ₹23,842.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹11,500.00 and a high of ₹24,225.00. On the performance front, Neuland Lab share price has increased by 84.10% over the last six months and is up 66.07% on a year-on-year basis.

₹23,460.00
2.02% down today
₹24,225.00
1D LOW
1D HIGH

Neuland Lab Returns Calculator

Circuit
L
H
₹19,200.00
₹28,790.00
52-week
L
H
₹11,500.00
₹24,225.00

About Neuland Lab

Neuland Lab Share Price
ISIN
INE794A01010
Sector Market Cap
₹ 30,758 Cr

Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.

Neuland Lab Financial Highlights

  • Revenue: Neuland Lab reported revenue of ₹2,053.16 crore in FY26 vs ₹1,497.35 crore in FY25. It showed an increase of 37.12% on a yearly basis.
  • Operating Profit: Neuland Lab reported an operating profit of ₹488.98 crore in FY26 vs ₹346.33 crore in FY25. It showed an increase of 41.19% on a year-on-year basis.
  • Net Profit: Neuland Lab reported a net profit of ₹364.00 crore in FY26 vs ₹260.11 crore in FY25. It showed an increase of 39.94% on a yearly basis.

Neuland Lab Quarterly Result Highlights

  • Neuland Lab reported revenue of ₹650.07 crore in Jun 2026, compared with ₹788.71 crore in Mar 2026, representing a decrease of 17.58% on a quarter-on-quarter (QoQ) basis.
  • Neuland Lab reported an operating profit of ₹197.85 crore in Jun 2026, compared with ₹287.49 crore in Mar 2026, representing a decrease of 31.18% on a quarter-on-quarter (QoQ) basis.
  • Neuland Lab reported a profit of ₹147.67 crore in Jun 2026, compared with ₹212.67 crore in Mar 2026, reflecting a decrease of 30.56% on a QoQ basis.
  • The earnings per share (EPS) of Neuland Lab stood at ₹283.71 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
32.62%
FII
21.08%
Other DII
3.85%
Retail and other
29.79%
Mutual funds
12.66%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202520.60%
Dec 202520.90%
Mar 202620.46%
Jun 202621.08%
Mkt Cap Cr
30,758.00
P/E
61.79
P/B
16.42
ROE
19.42%
D/E
0.16
ROCE
23.57%
Div. Yield
0.14%
EPS(TTM)
283.01
Turnover
0.81
EV/EBITDA
36.90
Net Margin
17.95%
Op. Margin
29.83%
ROA
16.99%
Quick Ratio
1.35
Curr. Ratio
2.18
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Neuland Labs. outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Neuland Labs. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Neuland Labs. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,826.0037.255.4013.74%0.6117.33%93.240.85%0.4810.90
Divis Laboratories2,47,019.0086.8615.1615.32%0.0019.56%629.490.31%0.5598.19
Torrent Pharmaceuticals1,88,767.0087.5622.4525.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,713.0024.984.2318.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,804.0033.323.2511.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,05,118.0096.4119.8316.77%0.4016.14%97.200.10%0.6713.72
Lupin96,574.5017.404.3023.76%0.0424.88%659.000.85%0.57129.18
Mankind Pharma95,242.0046.065.8411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories95,570.9030.192.5211.07%0.1812.54%377.950.70%0.4138.68
Aurobindo Pharma95,397.7026.142.569.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Neuland Lab Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,022.99₹1,476.84₹1,558.58₹1,191.20
Other Income₹30.17₹20.51₹12.54₹9.75
Total Revenue₹2,053.15₹1,497.35₹1,571.12₹1,200.95
Total Expenses₹1,564.17₹1,227.42₹1,169.69₹985.20
Profit Before Tax₹488.98₹346.33₹401.44₹215.75
Tax₹124.98₹86.22₹101.36₹52.23
Profit After Tax₹364.00₹260.11₹300.08₹163.52
EPS - Basic₹283.71₹202.74₹233.89₹127.45
EPS - Diluted₹283.71₹202.74₹233.89₹127.45

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹488.98₹346.33₹401.44₹215.75
Income before WC changes₹591.63₹334.35₹463.51₹293.67
Change in Assets-₹359.46₹28.58-₹99.00-₹153.28
Change in Liabilities₹218.04₹29.21₹8.27₹140.45
Change in WC-₹141.42₹57.78-₹90.73-₹12.83
Cash flow from Operations₹346.68₹317.40₹261.18₹237.21
Cash flow from Investing-₹423.73-₹298.16-₹149.69-₹61.50
Cash flow from Financing₹20.98₹24.96-₹69.28-₹135.80
Total Cash Flow-₹56.08₹44.21₹42.21₹39.92
Cash (Start of the year)₹131.93₹87.58₹45.42₹5.09
Cash (End of the year)₹76.67₹131.93₹87.58₹45.42

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,447.01₹1,040.38₹911.48₹818.87
Current Assets₹1,483.13₹1,139.50₹921.08₹760.89
Total Assets₹2,930.14₹2,179.88₹1,832.56₹1,579.76
Current Liabilities₹710.20₹465.69₹427.68₹438.96
Net Current Asset₹772.93₹673.81₹493.40₹321.94
Non-Current Liabilities₹345.47₹189.39₹122.17₹146.71
Equity Capital₹1,874.47₹1,524.81₹1,282.70₹994.10
Total Equity & Liabilities₹2,930.14₹2,179.88₹1,832.56₹1,579.76

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,022.99₹1,476.84₹1,558.58₹1,191.20
Other Income₹30.16₹20.51₹12.54₹9.75
Total Revenue₹2,053.15₹1,497.35₹1,571.12₹1,200.95
Total Expenses₹1,565.42₹1,228.38₹1,170.36₹985.73
Profit Before Tax₹487.73₹345.37₹400.77₹215.21
Tax₹124.63₹85.95₹101.17₹52.09
Profit After Tax₹363.11₹259.43₹299.60₹163.12
EPS - Basic₹283.01₹202.20₹233.51₹127.14
EPS - Diluted₹283.01₹202.20₹233.51₹127.14

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹487.73₹345.37₹400.77₹215.21
Income before WC changes₹590.38₹333.38₹462.84₹293.14
Change in Assets-₹359.18₹28.60-₹98.86-₹153.35
Change in Liabilities₹219.78₹30.15₹7.64₹142.31
Change in WC-₹139.40₹58.75-₹91.22-₹11.04
Cash flow from Operations₹347.58₹317.51₹260.06₹238.53
Cash flow from Investing-₹423.74-₹298.14-₹149.67-₹61.50
Cash flow from Financing₹20.98₹24.96-₹69.28-₹135.80
Total Cash Flow-₹55.18₹44.33₹41.11₹41.24
Cash (Start of the year)₹130.38₹86.07₹44.96₹3.72
Cash (End of the year)₹75.31₹130.38₹86.07₹44.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,446.97₹1,040.35₹911.46₹819.00
Current Assets₹1,481.37₹1,137.82₹919.47₹760.34
Total Assets₹2,928.34₹2,178.17₹1,830.93₹1,579.34
Current Liabilities₹719.24₹472.84₹433.80₹445.75
Net Current Asset₹762.12₹664.98₹485.67₹314.59
Non-Current Liabilities₹343.24₹187.54₹120.59₹145.22
Equity Capital₹1,865.85₹1,517.79₹1,276.54₹988.36
Total Equity & Liabilities₹2,928.34₹2,178.17₹1,830.93₹1,579.34
* All values are in INR Crore
Qty
Bid
7
23510
31
23505
12
23500
7
23495
21
23490
Ask
Qty
23535
8
23540
12
23545
16
23550
15
23555
9
Bid Total: 78
Ask Total: 60
Buy orders: 57%
Sell orders: 43%
Bearish
3
Neutral
4
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
67.62
Neutral
ATR (14)
581.93
Neutral
STOCH(9,6)
93.77
Bearish
STOCH RSI (14)
77.43
Neutral
ADX(9)
33.82
Bearish
UO(9)
54.04
Neutral
ROC(12)
2.98
Bullish
WillR(14)
-6.23
Bearish
Period
Simple value
Exponential vaue
5D
23075
23257.27
10D
23165.6
23138.19
20D
23186.8
22763.67
50D
20962.62
21216.68
100D
18797.24
19346.33
Volume trend — traded volume by day
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
3 Sep0L
2 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Neuland Lab Share Price
Neuland Lab
Pharmaceuticals
Add Stock
Add Another

Neuland Lab Share Price FAQs

Neuland Lab share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837